Going over the Plan

The media so clearly tip their hand and reveal their own abortion advocacy in the words they use to report on anything related to it. This is common in a lot of the MSM, but the Wall Street Journal is usually more even-handed. 

Not in this story on the FDA approval of over-the-counter sale of the morning-after pill. 

Antiabortion groups criticized yesterday’s decision and said it wouldn’t prevent young teens from getting Plan B without a prescription. On the other side, reproductive-rights groups, which had argued that easy access to Plan B would be a vital tool against unintended pregnancies, applauded the decision but said the age restriction was unnecessary.

Notice the terminology. “Antiabortion groups” on the one side, and “reproductive-rights groups” on the other. The anti-abortion group “criticized,” while the “reproductive rights” group “applauded.” Cue the reader to think negative and positive thoughts in appropriate places.

In this WSJ article listing common questions about Plan B, the answers lead to more questions — or they should.

Plan B effectively functions like a high dose of birth-control pills.

So why allow it to be sold over-the-counter, when the lower dose birth control pills are prescription only?

Scientists believe the resulting surge of hormones interferes with ovulation and fertilization or may prevent implantation of a brand-new embryo in the uterus.

A “brand-new embryo” is newly conceived human life, and that is inarguable. The embryo is of the species homo sapiens, nobody denies that. So preventing implantation aborts that human life.

The FDA has been struggling with Barr Pharmaceuticals and its subsidiary, Duramed, for years over their application to permit OTC sales of the ‘morning after pill.’ And yet, this action to approve it came up so suddenly last week, it stunned even Barr. Why?

The news release doesn’t address that. In fact, it sounds like it was hastily put together as well.

Duramed’s application raised novel issues regarding simultaneously marketing both prescription and non-prescription Plan B for emergency contraception, but for different populations, in a single package.

What?! Does anyone understand what that says, or means?

The agency remains committed to a careful and rigorous scientific process for resolving novel issues in order to fulfill its responsibility to protect the health of all Americans.

This is politically correct language. Whatever “novel issues” are, they obviously don’t apply to the smallest and most vulnerable of all Americans.